Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors

Methods for treating inflammatory bowel disease using prostate specific membrane antigen (PSMA) inhibitors

US Patent 10172873 · Granted Jan 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer ima2025
Prodrugs of 2-PMPA for healthy tissue protection during PSMA-targeted cancer ima2025
Use of itaconate and its derivatives/analogues to induce hair growth2025
Use of itaconate and its derivatives/analogues to induce hair growth2025
Prodrugs of itaconate and methyl itaconate2025
Prodrugs of itaconate and methyl itaconate2025
Glutamine antagonists and uses thereof2025
Glutamine antagonists and uses thereof2025
Small molecule neutral sphingomyelinase 2 (nSMase2) inhibitors2025
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor2024
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor2024
Prodrugs of glutamine analogs2024